Literature DB >> 10911753

[Treatment of arterial hypertension and sexual dysfunctions. Is it a certain cause of poor treatment compliance?].

L Reuge1, B Rüedi, G Guelpa.   

Abstract

The great interest risen by sildenafil (Viagra) resulted in talking again about erectif dysfunction and sexual disorders. Its commercial introduction has already renewed speech and social representation about sexuality. Each of the antihypertensive drug classes is know to generate sexual disorders. In reducing or normalising blood pressure, they decrease intracavernous perfusion pressure, already compromised by vascular disease of the hypertensive patient. This is due less to a side effect than to the logical consequence of treatment. Analysing last 15 years' medical publications shows little interest in searching for sexual side effects of hypertensive medication, in both sexes. In its every day practice, the physician can more easily have an opinion about their repercussions, than by reading studies, with mention of erectile dysfunction percentages often lower then the known prevalence in general population. However, if we want to improve therapeutic observance, whereas nearly half of the hypertensive patients are not compliant, we need to remedy. The solution would be improving patient-physician communication and relationship, and preventing potentially harmful effects of each antihypertensive agent by proceeding, if possible, to a sexually oriented history taking and physical examination before and during the treatment. This article reviews the works especially about sexual side effects of antihypertensive drug therapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10911753

Source DB:  PubMed          Journal:  Rev Med Suisse Romande        ISSN: 0035-3655


  3 in total

1.  The penis as a barometer of endothelial health.

Authors:  Andrew R McCullough
Journal:  Rev Urol       Date:  2003

2.  Four-year review of sildenafil citrate.

Authors:  Andrew R McCullough
Journal:  Rev Urol       Date:  2002

3.  Anthropological approach of adherence factors for antihypertensive drugs.

Authors:  Aline Sarradon-Eck; Marc Egrot; Marie Anne Blance; Muriella Faure
Journal:  Healthc Policy       Date:  2010-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.